Trump nominates pharma insider Azar to lead HHS

Share

Azar's nomination comes after Trump's initial health secretary, former U.S. Representative Tom Price, resigned in September amid criticism over his use of expensive taxpayer-funded private charter jets for government travel instead of cheaper commercial flights. "I don't think anybody can question his credentials from an experience perspective".

Azar's Senate confirmation could be hard, with the chamber's 48 Democrats unlikely to approve a candidate who supports dismantling the Affordable Care Act. But it is highly unlikely that a pharmaceutical company executive who has made passionate arguments against price restraints is going to advance real reform. He also pointed to Eli Lilly raising drug prices by double digits while Azar was an executive at the company. We need an HHS secretary who is willing to take on the greed of the pharmaceutical industry and lower prescription drug prices, not one who has financially benefitted from this greed.

Thomas Chandy to move SC against HC order
The opposition Congress-led UDF and the BJP have been demanding the resignation of Chandy over allegations of land encroachment. Consultations would be held with the Chief Minister and the leaders of the Left Democratic Front in the meantime, he said.

Azar, though a spokesman, declined to comment. It will be interesting to see if Azar attempts to unravel his personal holdings prior to confirmation hearings, or go the route that Trump and many of his other Cabinet picks have and just ignore the norm of divestiture for public service. His supporters say that Azar's understanding of the complicated dynamics behind pharmaceuticals pricing will give him an advantage in figuring out how to make drugs more affordable.

Alex Azar is the latest Hoosier headed to Washington for a post in the federal health sector.

Stretchy Stuffing Pants are Ideal Thanksgiving Trousers and a Fashion Nightmare
The trousers are available at www.thanksgivingdinnerpants.com for $19.98 in sizes from small to extra large. But I can count on zero hands the number of times I wanted to wear my stuffing-love on my sleeve.

Currently, Azar is the chairman and founder of Seraphim Strategies, which provides strategic consulting and counsel on biopharmaceutical and health insurance industries.

Azar's nomination must be approved by the Senate. He served as the HHS deputy secretary under President George W. Bush.

Kansas nearly finished with corn, soybean harvests
CBOT December corn settled up 2 cents at $3.43-1/2 per bushel, holding above the contract low set Thursday at $3.40-3/4. Commodity Futures Trading Commission is scheduled to release its weekly Commitments of Traders reports at 3:30 p.m.

Share